Cara Therapeutics Inc.

Rank 20
About
Cara Therapeutics is a biopharmaceutical company that focuses on the development of compound-based treatments for pain, inflammation, and pruritus. Several of its products are in the preclinical stage of development, including KORSUVA, oral KORUSUVA, and CR845/CR701. While the company is based in Stamford, Connecticut, it has plans to expand into Asian markets.
$8.4700
USD
2.87%
Market cap
$393,157,919
Total volume
$2,388,014
Shares outstanding
46,417,700
Rank 20
About
Cara Therapeutics is a biopharmaceutical company that focuses on the development of compound-based treatments for pain, inflammation, and pruritus. Several of its products are in the preclinical stage of development, including KORSUVA, oral KORUSUVA, and CR845/CR701. While the company is based in Stamford, Connecticut, it has plans to expand into Asian markets.
Markets
Exchange | Symbol | Volume (24h) | Volume (%) | Price |
---|---|---|---|---|
|
CARA |
$2,388,014
|
100% |
$8.4700
|
Chart